Skip to main content

/ health information/ Group items tagged #Non_Small_Cell_Lung_Cancer

Group items tagged

Filter: All | Bookmarks | Topics Simple Middle

ESMO 2019: Samsung Bioepis reveals Bevacizumab biosimilar trial result - 1 views

www.clinicaltrialsarena.com/...samsung-bevacizumab-biosimilar

#esmo_2019 #Samsung_Bioepis_reveals # esmo_2019_dates #Bevacizumab #biosimilar_trial_result #non_small_cell_lung_cancer.

shared by jacob logan on 03 Oct 19 - No Cached

jacob logan on 03 Oct 19

A Phase 3 study comparing Samsung Bioepis' SB8 with Avastin in patients with metastatic or recurrent non-squamous non-small cell lung cancer (NSCLC) demonstrated equivalent efficacy in terms of risk ratio of overall response rate (ORR).

<div class="cArrow"> </div><div class="cContentInner">A Phase 3 study comparing Samsung Bioepis' SB8 with Avastin in patients with metastatic or recurrent non-squamous non-small cell lung cancer (NSCLC) demonstrated equivalent efficacy in terms of risk ratio of overall response rate (ORR).</div>

...

Cancel

Blood test may replace biopsy in advanced lung cancer - 1 views

www.medicaldevice-network.com/...lung-cancer-blood-test

#Blood_Test #Replace_Biopsy #Lung_Cancer #NSCLC #Non_Small_Cell_Lung_Cancer #Small_Lung_Cancer #Tumor #Tumor_Treatment

shared by jacob logan on 22 Oct 19 - No Cached

jacob logan on 22 Oct 19

Patients with advanced non-small cell lung cancer (NSCLC) may soon be offered a blood test to assess their treatment options, instead of having to provide a tumour sample for analysis.

<div class="cArrow"> </div><div class="cContentInner">Patients with advanced non-small cell lung cancer (NSCLC) may soon be offered a blood test to assess their treatment options, instead of having to provide a tumour sample for analysis.</div>

...

Cancel

1 - 2 of 2

Showing 20▼ items per page

Related searches